NAFDAC, CACPP fault continued drug counterfeiting, canvass awareness
National Agency for Food and Drug Administration and Control (NAFDAC) and members of the Coalition Against Counterfeit Pharmaceutical Products (CACPP) have expressed concern over continued drug counterfeiting in the country, insisting effort in changing the narrative cannot be overemphasized.
Speaking at a stakeholder meeting in Lagos, yesterday, the members unanimously observed that perpetrators are devising new ways of promoting their illicit trade and that uncoordinated supply chains also aid counterfeiting.
The CACPP members include: CMC Connect, Nigerian Representatives of
Overseas Manufacturers (Niropharm), and Pharmaceutical Wholesalers and Distributors Association of Nigeria (PWDAN).
Deputy Director, of Investigation and Enforcement, NAFDAC, Uba Florence, noted that fake drugs and counterfeiting are a life and death issue. She said NAFDAC will not relent and stressed the need for more collaboration and partnerships.
Group Managing Director at CMC Connect, Yomi Badejo-Okusanya, called for urgent action against counterfeiting, pointing out challenges, such as poverty, ignorance and self-prescription.
To achieve this objective, he advocated the use of jingles, commercials, animated series, influencers and brand ambassadors.
Country Manager, Pfizer, Yinka Subair, said the regulator is doing a good job but argued that awareness is key. He said patients must be enlightened on the dangers of patronising counterfeited drugs and where to get originals.